Bleakley Financial Group, LLC Treace Medical Concepts, Inc. Transaction History
Bleakley Financial Group, LLC
- $3.28 Trillion
- Q3 2024
A detailed history of Bleakley Financial Group, LLC transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 22,142 shares of TMCI stock, worth $173,371. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,142
Previous 80,936
72.64%
Holding current value
$173,371
Previous $538 Million
76.14%
% of portfolio
0.0%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding TMCI
# of Institutions
138Shares Held
39.7MCall Options Held
352KPut Options Held
269K-
Armistice Capital, LLC New York, NY6.2MShares$48.5 Million0.6% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$31.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.27MShares$25.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.74MShares$21.5 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.39MShares$18.7 Million0.04% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $434M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...